porphobilinogen has been researched along with Diabetes Mellitus, Adult-Onset in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Johns, M | 1 |
| Fyalka, R | 1 |
| Shea, JA | 1 |
| Neumann, WL | 1 |
| Rausaria, S | 1 |
| Msengi, EN | 1 |
| Imani-Nejad, M | 1 |
| Zollars, H | 1 |
| McPherson, T | 1 |
| Schober, J | 1 |
| Wooten, J | 1 |
| Kwon, G | 1 |
| Andersson, C | 1 |
| Bylesjö, I | 1 |
| Lithner, F | 1 |
2 other studies available for porphobilinogen and Diabetes Mellitus, Adult-Onset
| Article | Year |
|---|---|
SR-135, a peroxynitrite decomposing catalyst, enhances β-cell function and survival in B6D2F1 mice fed a high fat diet.
Topics: Animals; Apoptosis; Blood Glucose; Cell Survival; Diabetes Mellitus, Type 2; Diet, High-Fat; Glucose | 2015 |
Effects of diabetes mellitus on patients with acute intermittent porphyria.
Topics: Age of Onset; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Diabetes Mellitus, Type 2; Female; | 1999 |